6/11
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Low
Report
Arcus Biosciences Announces New Employment Inducement Grants
6/10
08:49 am
rcus
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers [Yahoo! Finance]
Medium
Report
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers [Yahoo! Finance]
6/10
08:30 am
rcus
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers
Medium
Report
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers
6/7
12:17 pm
rcus
Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock? [Yahoo! Finance]
Low
Report
Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock? [Yahoo! Finance]
6/6
04:05 pm
rcus
Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Low
Report
Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
6/3
12:08 pm
rcus
Arcus Biosciences, Inc. (NYSE: RCUS) had its price target raised by analysts at Citigroup Inc. from $36.00 to $38.00. They now have a "buy" rating on the stock.
Medium
Report
Arcus Biosciences, Inc. (NYSE: RCUS) had its price target raised by analysts at Citigroup Inc. from $36.00 to $38.00. They now have a "buy" rating on the stock.
6/2
08:00 am
rcus
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
Medium
Report
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
6/1
08:00 am
rcus
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
Medium
Report
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
5/31
07:01 am
rcus
It's Unlikely That Arcus Biosciences, Inc.'s (NYSE:RCUS) CEO Will See A Huge Pay Rise This Year [Yahoo! Finance]
Low
Report
It's Unlikely That Arcus Biosciences, Inc.'s (NYSE:RCUS) CEO Will See A Huge Pay Rise This Year [Yahoo! Finance]
5/24
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Medium
Report
Arcus Biosciences Announces New Employment Inducement Grants
5/15
04:14 am
rcus
Arcus Biosciences: A Preview Of Their Outlook Ahead Of ASCO [Seeking Alpha]
Medium
Report
Arcus Biosciences: A Preview Of Their Outlook Ahead Of ASCO [Seeking Alpha]
5/12
08:52 am
rcus
Arcus Biosciences, Inc. (NYSE:RCUS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates [Yahoo! Finance]
Low
Report
Arcus Biosciences, Inc. (NYSE:RCUS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates [Yahoo! Finance]
5/9
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Medium
Report
Arcus Biosciences Announces New Employment Inducement Grants
5/9
04:00 pm
rcus
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/9
09:06 am
rcus
Arcus Biosciences, Inc. (NYSE: RCUS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $30.00 price target on the stock.
Low
Report
Arcus Biosciences, Inc. (NYSE: RCUS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $30.00 price target on the stock.
5/8
07:34 pm
rcus
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
5/8
05:06 pm
rcus
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update [Yahoo! Finance]
Low
Report
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update [Yahoo! Finance]
5/8
04:02 pm
rcus
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update
Medium
Report
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update
5/2
04:05 pm
rcus
Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024
Low
Report
Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024
5/1
11:25 am
rcus
Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know [Yahoo! Finance]
Low
Report
Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know [Yahoo! Finance]
4/24
04:14 pm
rcus
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting [Yahoo! Finance]
Medium
Report
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting [Yahoo! Finance]
4/24
04:00 pm
rcus
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting
Medium
Report
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting
4/23
04:20 pm
rcus
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update [Yahoo! Finance]
Low
Report
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update [Yahoo! Finance]
4/23
04:05 pm
rcus
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
Low
Report
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
4/9
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Medium
Report
Arcus Biosciences Announces New Employment Inducement Grants